Quantcast

The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas.

Research paper by Regina R Landesberg, Victoria V Woo, Linda L Huang, Matthew M Cozin, Yan Y Lu, Cory C Bailey, Wu W Qu, Carla C Pulse, Ann Marie AM Schmidt

Indexed on: 22 Jan '08Published on: 22 Jan '08Published in: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics



Abstract

Advanced glycation endproducts (AGEs) and their receptors, receptor for advanced glycation endproducts (RAGE), are novel groups of molecules with roles in inflammation, cytokine activation, and promotion of cell growth. Recently, RAGE has been implicated in the progression and metastasis of several epithelial tumors. The expression of RAGE was examined in 38 oral squamous cell carcinoma (OSCC) cases by immunohistochemistry. In the OSCCs, RAGE positivity, interpreted as more than 25% positive cells, was detected in 10 of 10 well-differentiated, 3 of 4 well-to-moderately differentiated, 3 of 9 moderately differentiated, 1 of 7 moderate-to-poorly differentiated, and 0 of 8 poorly differentiated tumors. The staining percentage was significantly higher in well-differentiated tumors compared to moderately (P < .05) and poorly differentiated (P < .05) tumors. All normal mucosa samples were RAGE-positive. Western blot analysis for RAGE was performed on 2 OSCCs and 2 normal oral mucosa samples. Higher expression was observed in the normal tissues compared to the OSCCs. Our results show that RAGE immunoreactivity correlates with histologic differentiation in OSCC.